The India hemoglobin testing market size reached USD 80.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 130.0 Million by 2033, exhibiting a growth rate (CAGR) of 5.2% during 2025-2033. The growing adoption of point-of-care testing (POCT) devices, driven by technological advancements and government initiatives, is significantly boosting the India hemoglobin testing market by enabling rapid, cost-effective, and accessible diagnostics, particularly in rural and remote areas, thereby improving early detection and management of anemia across diverse population segments.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 80.0 Million |
Market Forecast in 2033 | USD 130.0 Million |
Market Growth Rate (2025-2033) | 5.2% |
Government Initiatives and Increased Healthcare Expenditure
The Indian government's investment in developing healthcare infrastructure and services has been a key catalyst for the hemoglobin testing market. Heavy investments in public health have resulted in better diagnostic facilities and greater availability of vital medical tests, including hemoglobin tests. As per the National Health Accounts (NHA) Estimates for 2020-21 and 2021-22, the proportion of government health spending in the overall health spending surged from 29% in 2014-15 to 48% in 2021-22. This substantial boost reflects the government's commitment to enhancing healthcare services throughout the country. A key initiative is the National Health Mission (NHM), whose goal is to deliver universal access to equitable, affordable, and quality healthcare services. The NHM has played a critical role in escalating healthcare coverage, especially in rural and underserved communities, thus driving the demand for diagnostic tests such as hemoglobin testing. The amplifying emphasis on child and maternal health under NHM has also led to a rise in the requirement for routine hemoglobin screening to detect and prevent anemia in pregnant women and children.
Rising Prevalence of Hemoglobin Disorders
The rising incidence of hemoglobin disorders, including anemia, has contributed majorly to the development of the hemoglobin test market in India. Anemia, which is defined by low hemoglobin levels, impacts a considerable percentage of the Indian population, especially women and children. Normal hemoglobin checking is important for the early diagnosis and care of anemia, thereby elevating the demand for such diagnostic procedures. The proactive role of the government in combating anemia is reflected through several programs and policies. For example, the Anemia Mukt Bharat (AMB) program focuses on decreasing the rate of anemia among vulnerable populations such as pregnant women, adolescents, and children. The program focuses on frequent screening and early treatment, thus enhancing the need for hemoglobin testing. The National Family Health Survey (NFHS-5) figures reveal that the prevalence of anemia in women aged 15-49 years was 57.0% in 2019-21, which signifies the urgent necessity for continuous surveillance and intervention. Furthermore, the inclusion of hemoglobin testing under routine health check-ups and school health programs further strengthened the market. Early identification through mass screening enables early intervention, lessening the load of hemoglobin diseases and improving population health in general.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region/country level for 2025-2033. Our report has categorized the market based on product type, technology, and end-user.
Product Type Insights:
The report has provided a detailed breakup and analysis of the market based on the product type. This includes reagents and consumables, and equipment.
Technology Insights:
A detailed breakup and analysis of the market based on technology have also been provided in the report. This includes chromatography, immunoassay, and others.
End User Insights:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes laboratories, hospitals, and research centers.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Product Types Covered | Reagents and Consumables, Equipment |
Technologies Covered | Chromatography, Immunoassay, Others |
End Users | Laboratories, Hospitals, Research Centers |
Regions Covered | North India, South India, East India, West India |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: